Celera Completes Split from Applera; Adds Two Directors, Plans Shift in Fiscal Year | GenomeWeb
NEW YORK (GenomeWeb News) – Celera said today that it has completed its separation from Applera and is now trading as an independent publicly traded firm on the Nasdaq exchange under the ticker symbol “CRA.”
 
Applera, meantime, has changed its name to Applied Biosystems Inc. Its stock will continue to be listed on the New York Stock Exchange under the symbol "ABI."
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Some science companies will be taking part in next month's March for Science, Fortune reports.

In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.

Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.